Výsledky vyhledávání - "Enas Mutahar"

Akademický článek

Risk assessment for newly diagnosed, fit and young patients with Multiple Myeloma, in the era of novel treatment modalities: Are there any additional factors to be under consideration?

Autor: Panayotis Kaloyannidis, Fatema Abdulla, Enas Mutahar, Haidar Hashim, Salman Harbi, Analie Estanislao, Solaf Ka

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S33- (2022)

Objective: Multiple myeloma (MM) is considered a disease of elderlies however, 35-40% of newly diagnosed MM (NDMM) patients (pts) are ≤60 years (ys) old. Although young NDMM pts succeed better outcomes with the currently used treatment protocols, a

Externí odkaz: https://doaj.org/article/b3127f242686407a9f4f61e1f65e3724

Zobrazit plný text záznamu

Risk Assessment for Newly Diagnosed Fit Young Patients with Multiple Myeloma in the Era of Novel Treatment Modalities: Should There Be Additional Factors Taken into Consideration??

Autor: Panayotis Kaloyannidis, Fatema Abdulla, Enas Mutahar, Haidar Al Hashim, Salman Al Harbi, Analie Estanislao, Hani Al Hashmi

Publikováno v: Journal of Blood Medicine.

Panayotis Kaloyannidis, Fatema Abdulla, Enas Mutahar, Haidar Al Hashim, Salman Al Harbi, Analie Estanislao, Hani Al Hashmi Adult Hematology and Stem Cell Transplantation Department, King Fahad Specialist Hospital, Dammam, Saudi ArabiaCorrespondence:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bed36f467cc287ab9eebc87df6a26167
https://www.dovepress.com/risk-assessment-for-newly-diagnosed-fit-young-patients-with-multiple-m-peer-reviewed-fulltext-article-JBM

Zobrazit plný text záznamu

BEAM Versus Single Agent High Dose Melphalan (HDM) Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplant (ASCT): A Retrospective Matched Analysis in Relapse/Refractory Hodgkin Lymphoma

Autor: Infran Maghfoor, Eshrak Al Shaibani, Ioannis Apostolidis, Mohamad Darweesh, Harbi Salman, Enas Mutahar, Khalid Al Anezi, M S Rauf, Panayotis Kaloyannidis, Jenifer Bacal, Hani Al Hashmi, Tusneem Elhassan, Solaf Kafnar, Saad Akhtar

Publikováno v: Biology of Blood and Marrow Transplantation. 25:S187-S188

Background The ideal conditioning regimen still remains a challenge in the autologous stem cell transplantation (ASCT) setting for relapsed/refractory Hodgkin Lymphoma (RR-HL). BEAM is the most popular preparative regimen but single agent high dose M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5e345f0aba41c35c08b8ab87624c4132
https://doi.org/10.1016/j.bbmt.2018.12.773

Zobrazit plný text záznamu

Favorable Outcome after Adjuvant Involved Field Irradiation Post Autologous Stem Cell Transplantation in Refractory/Relapsed Lymphomas: A Single Center Experience

Autor: Eshrak Al Shaibani, Mohamad Darweesh, Ioannis Apostolidis, Enas Mutahar, Ahmed Buali, Solaf Kafnar, Eman Debawy, Rawan Omari, Khalid Al Anezi, Panayotis Kaloyannidis, Jenifer Bacal, Reem Khalili, Hani Al Hashmi

Publikováno v: Biology of Blood and Marrow Transplantation. 25:S397-S398

Introduction Patients with Hodgkin (HL) or Non-Hodgkin Lymphoma (NHL) who have either bulky masses at relapse or residual disease post salvage therapy, have poor outcome even after autologous stem cell transplantation (ASCT). Involved field radiother

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::647d0b38be4653a6684e058052259cef
https://doi.org/10.1016/j.bbmt.2018.12.811

Zobrazit plný text záznamu

Metabolic Syndrome Post Allogeneic STEM CELL Transplantation in Adult Patients Is NOT an Uncommon Complication. a Single Center Experience

Autor: Enas Mutahar, Khalid Ahmed Al-Anazi, Deia Awami, Panayotis Kaloyannidis, Heba Raslan, Rabab Al Attas, Hani Al Hashmi, Mohammed Darweesh, Zahra Abdrabalamir Alshammasi, John Apostolidis, Ahmed Al Bahrani, Solaf Kanfar

Publikováno v: Blood. 134:5695-5695

Background: The significant advances which have been achieved in the field of allogeneic transplantation (alloHCT) have resulted in better post-transplant outcome and prolonged survival. Therefore, complications other than the Graft vs. Host disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::10908b2b60b98cd84c08460e8b11a60d
https://doi.org/10.1182/blood-2019-129045

Zobrazit plný text záznamu

Alterations of Gut Microbiome in Untreated Chronic Lymphocytic Leukemia (CLL); Future Therapeutic Potentials

Autor: Ibrahim Baydoun, Nihad Mokhtar, Enas Mutahar, Mahmood Akhtar, Solaf Kanfar, John Apostolidis, Mohamed Sager, Juma H. Kabanja, Khalid Ahmed Al-Anazi, Mohammed Darweesh, Mohammed Kawari, Hani Al Hashmi, Zakaria Basbous

Publikováno v: Blood. 134:5455-5455

Introduction: Gut dysbiosis is an imbalance of the gut microbiome. The presence of dysbiosis can be a cause of systemic inflammation in the body or can be a contributing factor to it. Chronic systemic inflammation is a common feature of CLL, creating

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c5dd67719f1e35707d79c5b91a8778c6
https://doi.org/10.1182/blood-2019-121643

Zobrazit plný text záznamu

Is There Any Impact of Uric Acid Levels during the Peri-Transplant Period on Acute Graft Vs. Host Disease Incidence and Allotransplant Outcome?

Autor: Norah Muhlem, Solaf Kanfar, Abdulhamid Liacini, Hussin Alsubaie, Khalid Ahmed Al-Anazi, Zahra Abdrabalamir Alshammasi, Afra Dayel, Hani Al Hashmi, Panayotis Kaloyannidis, Mohammed Darweesh, Enas Mutahar, John Apostolidis, Kenana Ajlan, Ahmed Al Bahrani, Rawan Omari

Publikováno v: Blood. 134:5681-5681

Background: Damage associated molecular patterns (DAMPs) are considered important contributors to acute Graft vs Host Disease (aGvHD) pathogenesis. Uric acid (UA), a DAMPs family molecule, upon its release from damaged tissues post high dose chemo/ra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5f25895a16f8cb183a50616bf21cf366
https://doi.org/10.1182/blood-2019-128651

Zobrazit plný text záznamu

Could the Intensification of Salvage Regimens Safely Overcome the Lymphoma Disease Resistance?

Autor: Hani Al Hashmi, Reem Khalili, Eshrak Al Shaibani, Mohamad Darweesh, Khalid Al Anezi, Solaf Kafnar, Panayotis Kaloyannidis, Ayed Garni, Jenifer Bacal, Ioannis Apostolidis, Enas Mutahar

Publikováno v: Biology of Blood and Marrow Transplantation. 25:S393

Background Disease chemosensitivity to salvage treatment is a major predictive factor for a favorable outcome after autologous stem cell transplantation (ASCT) for patients with refractory lymphomas. Therefore the importance of effective and safe sal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9a413b03bc8b2165a1453cf7fa018e00
https://doi.org/10.1016/j.bbmt.2018.12.804

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání